Ignite Creation Date:
2024-05-06 @ 6:12 PM
Last Modification Date:
2024-10-26 @ 2:43 PM
Study NCT ID:
NCT05577468
Status:
COMPLETED
Last Update Posted:
2024-01-10
First Post:
2022-10-09
Brief Title:
Efficacy and Safety of Tegoprazan Versus Esomeprazole-containing Bismuth Quadruple Therapy for Eradication of Helicobacter Pylori
Sponsor:
Shandong Luoxin Pharmaceutical Group Stock Co Ltd
Organization:
Shandong Luoxin Pharmaceutical Group Stock Co Ltd
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-10-30
Start Date Type:
ACTUAL
Primary Completion Date:
2023-09-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-09-30
Completion Date Type:
ACTUAL
First Submit Date:
2022-10-09
First Submit QC Date:
October 9 2022
Study First Post Date:
2022-10-13
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-01-08
Last Update Post Date:
2024-01-10
Last Update Post Date Type:
ACTUAL